Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Value Growth And Long-Term Outlook
In recent years, the market size for shelter pathogen polymerase chain reaction (PCR) screening programs has demonstrated robust growth. It will grow from $1.1 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. This historical growth can be attributed to several factors, including an increase in infectious diseases within animal shelters, a greater embrace of molecular diagnostic methods, heightened understanding of zoonotic disease dangers, restricted access to quick testing solutions in shelters, and the proliferation of veterinary diagnostic facilities.
The market for shelter pathogen polymerase chain reaction (PCR) screening programs is projected to experience substantial expansion over the coming years. It is anticipated to reach $1.78 billion by 2030 at a compound annual growth rate (CAGR) of 10.1%. This projected increase during the forecast period stems from factors such as a heightened need for prompt disease detection in animal populations, the proliferation of automated and high-throughput PCR systems, growing financial commitments to animal health infrastructure, the broadening scope of preventive veterinary screening initiatives, and innovations in portable and point-of-care molecular diagnostics. Key developments expected during this period involve the widespread adoption of real-time PCR-based pathogen monitoring within animal shelters, a greater uptake of multiplex PCR testing for swift disease identification, increased deployment of automated nucleic acid extraction technologies in shelter diagnostic processes, the expanding incorporation of portable PCR devices for immediate screening purposes, and an amplified focus on preventing outbreaks through regular molecular screening efforts.
Get A Free Sample Report With In-Depth Market Insights:
Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Growth Drivers: What’s Behind The Acceleration?
An anticipated surge in infectious diseases affecting animals in shelters is projected to fuel the expansion of the shelter pathogen polymerase chain reaction (PCR) screening programs market in the coming years. These diseases, caused by detrimental pathogens like viruses and bacteria, spread quickly among dogs, cats, and other animals kept in close quarters within shelters. The increasing occurrence of such diseases in shelter environments is primarily due to a rise in animal admissions coupled with a decline in vaccination rates since the pandemic, leading to larger vulnerable populations in already packed facilities. The growing number of infectious disease cases in shelter animals directly increases the need for precise pathogen identification tools like polymerase chain reaction (PCR) screening, given that prompt and accurate detection of causal agents is vital for implementing effective strategies for containment and treatment at a population level. For example, in November 2023, the Colorado Department of Agriculture, a US-based state government agency, reported twice the usual number of canine infectious respiratory disease cases compared to a typical outbreak, with similar spikes recorded across at least 10 U. S. states between 2022 and 2023. Consequently, the rising incidence of infectious diseases in shelter animals is a key factor propelling the growth of the shelter pathogen polymerase chain reaction (PCR) screening programs market. The increasing trend of pet ownership is anticipated to boost the shelter pathogen polymerase chain reaction (PCR) screening programs market in the foreseeable future. Pet ownership describes the custom of having domesticated animals like dogs and cats as companions within residences. This expanding prevalence of pet ownership is largely fueled by changing views across generations, especially among younger groups who increasingly view pets as members of their families, thereby encouraging higher adoption rates in homes. The growing number of animals entering both private homes and animal shelters intensifies the demand for precise and swift pathogen detection methods, as a greater quantity of animals requires health checks prior to being adopted or placed to prevent the spread of diseases. For instance, in March 2025, data from the American Pet Products Association (APPA), a US-based trade organization, indicated that the overall count of U. S. pet-owning households increased from 82 million in 2023 to 94 million in 2024. Consequently, the rise in pet ownership is a significant factor propelling the growth of the pathogen polymerase chain reaction (PCR) screening programs market.
Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Segment Analysis Spotlighting Growth Areas
The shelter pathogen polymerase chain reaction (pcr) screening programs market covered in this report is segmented –
1) By Product Type: Polymerase Chain Reaction Test Kits, Nucleic Acid Extraction Kits, Real-Time Polymerase Chain Reaction Reagents, Polymerase Chain Reaction Primers And Probes, Sample Collection Swabs, Viral Transport Media, Microcentrifuge Tubes, Pipettes, Polymerase Chain Reaction Plates
2) By Screening Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Fungal Diseases, Other Screening Types
3) By Animal Type: Dogs, Cats, Other Animal Types
4) By Testing Method: Molecular Diagnostics, Serological Tests, Rapid Tests, Other Testing Methods
5) By End User: Animal Shelters, Veterinary Clinics, Research Institutes, Other End Users
Subsegments:
1) By Polymerase Chain Reaction Test Kits: Basic Detection Kits, Multiplex Detection Kits, Quantitative Polymerase Chain Reaction Kits, Point Of Care Kits, High Throughput Kits
2) By Nucleic Acid Extraction Kits: Manual Extraction Kits, Automated Extraction Kits, Spin Column Kits, Magnetic Bead Kits, Tissue And Blood Extraction Kits
3) By Real-Time Polymerase Chain Reaction Reagents: Polymerase Enzymes, Fluorescent Dyes, Master Mix Solutions, Buffer Solutions, Positive Control Reagents
4) By Polymerase Chain Reaction Primers And Probes: Custom Primers, Pre Designed Primers, Hydrolysis Probes, Molecular Beacon Probes, Dual Labeled Probes
5) By Sample Collection Swabs: Sterile Cotton Swabs, Synthetic Fiber Swabs, Flocked Swabs, Transport Swabs, Oral And Nasal Swabs
6) By Viral Transport Media: Liquid Transport Media, Freeze Dried Media, Universal Transport Media, Stabilizing Media, Antimicrobial Containing Media
7) By Microcentrifuge Tubes: Polypropylene Tubes, Graduated Tubes, Screw Cap Tubes, Flat Cap Tubes, Color Coded Tubes
8) By Pipettes: Single Channel Pipettes, Multi Channel Pipettes, Adjustable Volume Pipettes, Fixed Volume Pipettes, Electronic Pipettes
9) By Polymerase Chain Reaction Plates: Standard Polymerase Chain Reaction Plates, Optical Polymerase Chain Reaction Plates, Deep Well Polymerase Chain Reaction Plates, Sealable Polymerase Chain Reaction Plates, Strip Polymerase Chain Reaction Plates
Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the shelter pathogen polymerase chain reaction (PCR) screening programs market are concentrating on developing advanced molecular diagnostic solutions, such as rapid multiplex PCR tests. This effort aims to improve the speed of pathogen detection, enhance diagnostic accuracy, and facilitate timely disease management in high-risk animal populations. Rapid multiplex PCR tests are sophisticated molecular assays capable of simultaneously identifying multiple infectious pathogens from a single sample, thereby boosting workflow efficiency and shortening turnaround times in shelter environments. For instance, in June 2025, Enalees, a France-based veterinary diagnostics company, introduced Rhéa, a new line of veterinary rapid molecular tests designed for point-of-care application. These tests utilize real-time PCR technology to provide quick and dependable detection of infectious diseases in companion animals, aiding in early diagnosis and improved clinical decision-making, especially in settings like animal shelters where prompt screening and disease containment are critical.
Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Leading Players And Competitive Positioning
Major companies operating in the shelter pathogen polymerase chain reaction (pcr) screening programs market are Thermo Fisher Scientific Inc, Zoetis Inc, Eurofins Scientific SE, Agilent Technologies Inc, bioMérieux SA, IDEXX Laboratories Inc, Bio-Rad Laboratories Inc, QIAGEN NV, GenScript Biotech Corporation, Randox Laboratories Ltd, Bioneer Corporation, IDvet, Creative Diagnostics, Primerdesign Ltd (Novacyt Group), GeneReach Biotechnology Corp, Ring Biotechnology Co Ltd (RINGBIO), VetFor Diagnostic Systems, Invitek Diagnostics GmbH, ViroVet NV, BioVenic, Enzo Life Sciences Inc
View The Full Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Report:
Shelter Pathogen Polymerase Chain Reaction (PCR) Screening Programs Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the shelter pathogen polymerase chain reaction (PCR) screening programs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shelter pathogen polymerase chain reaction (PCR) screening programs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.